Peripapillary pachychoroid syndrome successfully treated with topical prednisolone acetate 1% drops

Lojain A Azizalrahman; Abdullah N Almousa; Fadwa Al Adel; Abdulrahman F AlBloushi

doi:10.4103/sjopt.sjopt_187_22

Peripapillary pachychoroid syndrome successfully treated with topical prednisolone acetate 1% drops

Saudi J Ophthalmol. 2023 Jul 8;38(1):89-91. doi: 10.4103/sjopt.sjopt_187_22. eCollection 2024 Jan-Mar.

Authors

Lojain A Azizalrahman¹, Abdullah N Almousa¹, Fadwa Al Adel², Abdulrahman F AlBloushi¹

Affiliations

¹ Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
² Department of Ophthalmology, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.

Abstract

Peripapillary pachychoroid syndrome (PPS) is a rare disease characterized by choroidal thickening around the optic disc. Visual acuity might be impaired secondary to the associated peripapillary intraretinal and/or subretinal fluids. We reported a case of a 70-year-old male patient who presented with a gradual bilateral decrease in vision. His best-corrected visual acuity was 20/60 in the right eye and 20/25 in the left eye. Dilated fundus examination showed yellowish peripapillary lesions and intraretinal fluid (IRF) surrounding the optic disc in both eyes. Optical coherence tomography showed that the outer retinal layers were disrupted, and IRF affected the nasal macula. A bilateral increase in the thickness of the choroid around the optic discs was found. The patient was successfully treated with a tapering dose of topical prednisolone acetate (1%). Three months after treatment, his vision improved to 20/25 in the right eye and 20/20 in the left eye. Topical steroid drops might be administered to treat PPS.

Keywords: Pachychoroid; peripapillary pachychoroid syndrome; prednisolone acetate.

Publication types

Case Reports